Medication Administration: Oral, IM, IV, SC, ID & Z-Track Technique

Medication administration is one of the most critical legal and therapeutic responsibilities of the professional nurse. Ensuring patient safety demands absolute mastery of pharmacokinetics, dosage calculations, anatomical landmark identification, aseptic injection techniques, and systematic verification protocols.

---

1. Principles of Safe Drug Administration

Medication errors represent a major source of preventable hospital harm. Clinical nursing practice utilizes structured verification frameworks to intercept errors before reaching the patient.

The Rights of Medication Administration

Historically taught as the Five Rights, modern evidence-based nursing encompasses Ten Rights of Drug Administration:

1. Right Patient: Verify identity using at least two independent identifiers (e.g., full legal name, hospital identification/MRN, and date of birth). Compare the client's hospital identification wristband against the Medication Administration Record (MAR). Never rely on room numbers or bed tags.
2. Right Medication: Confirm the medication label matches the MAR order precisely. Differentiate look-alike and sound-alike (LASA) drug names (e.g., hydralazine vs. hydroxyzine; prednisone vs. prednisolone).
3. Right Dose: Validate the prescribed dose against safe therapeutic dosage ranges, checking mathematical calculations independently for high-alert medications (e.g., insulin, heparin, inotropes, narcotics).
4. Right Route: Ensure the ordered formulation matches the prescribed route (e.g., never administer an oral liquid suspension intravenously).
5. Right Time: Administer within the designated clinical window (typically within 30 minutes before or after the scheduled time for time-critical medications, or 60 minutes for non-time-critical agents).
6. Right Documentation: Record administration immediately after completion, never before. Document drug name, dosage, route, anatomical site, exact time, pulse/blood pressure (if applicable), and signature/initials.
7. Right Reason / Indication: Confirm the clinical rationale for why the client requires the medication based on current diagnosis and pathophysiological state.
8. Right Assessment: Execute mandatory pre-administration assessments (e.g., apical pulse for 60 seconds prior to digoxin; blood pressure prior to antihypertensives; blood glucose prior to insulin).
9. Right Client Education: Explain the drug name, therapeutic intent, and anticipated side effects to the patient in understandable terms.
10. Right to Refuse: A mentally competent client possesses the autonomy to decline medication. The nurse must explore the rationale, explain consequences, notify the prescribing provider, and document the refusal.

The Three Checks of Medication Verification

The nurse cross-checks the medication label against the MAR at three distinct sequential checkpoints:

• First Check: When retrieving the medication container, unit-dose package, or vial from the automated dispensing cabinet (Pyxis), medication cart, or supply shelf.
• Second Check: When preparing the medication (drawing up liquids, measuring tablets, or calculating volume).
• Third Check: At the patient's bedside immediately before opening unit-dose packages or administering the medication to the client.

---

2. Enteral, Topical & Inhalation Routes

Enteral Routes (Oral, Sublingual, Buccal, Rectal)

• Oral (PO): The most common, convenient, and economical route. Medications are absorbed across gastric or intestinal mucosa.
  • Tablets and Capsules: Administer with 60–100 mL of water. Do not crush enteric-coated (EC) formulations (designed to protect gastric mucosa or avoid drug inactivation by stomach acid) or sustained-release (SR, ER, XR, CR) formulations (crushing causes dose-dumping and fatal toxicity).
  • Liquid Formulations: Read fluid meniscus at eye level on a flat surface using a calibrated oral syringe or medicine cup.
• Sublingual (SL): Placed directly beneath the tongue (e.g., Nitroglycerin). Bypasses first-pass hepatic metabolism via direct absorption into rich sublingual venous capillaries. Instruct patient not to chew, swallow, or drink fluids until fully dissolved.
• Buccal: Placed against the mucous membrane between the cheek and lower gum until dissolved. Alternate cheeks to prevent mucosal irritation.
• Rectal (PR): Indicated during severe nausea, vomiting, unconsciousness, or status epilepticus. Suppositories are inserted past the internal anal sphincter (approximately 2 to 4 inches or 5 to 10 cm in adults; 1 inch in infants) along the rectal wall. Position client in Left Lateral Sims' position with right knee flexed.

Topical, Ophthalmic & Otic Administration

• Transdermal Patches: Delivers systemic medication across intact skin (e.g., fentanyl, scopolamine, nitroglycerin). Always remove the old patch, clean the skin, rotate application sites to prevent dermal injury, and write the date, time, and initials on the new patch.
• Ophthalmic Drops: Position client supine or seated with head tilted backward. Cleanse eyelid margin from inner to outer canthus. Depress the lower lid to expose the lower conjunctival sac. Instill prescribed drops into the center of the conjunctival fornix (never directly onto the sensitive cornea). Instruct client to close eyes gently. Immediately apply firm digital pressure over the nasolacrimal duct (inner canthus) for 1 to 2 minutes to prevent drainage into the systemic circulation and minimize systemic toxicity (e.g., preventing systemic bradycardia from ophthalmic timolol).
• Otic (Ear) Drops: Solution must be at room temperature; instilling cold drops triggers profound vertigo and nausea via vestibular thermal shock.
  • Adults and Children > 3 Years: Pull the pinna upward and backward to straighten the S-shaped external auditory canal.
  • Infants and Children < 3 Years: Pull the pinna downward and backward.
  • Keep client positioned on side for 2 to 3 minutes to permit medication penetration.

---

3. Parenteral Administration: Needle Sizing, Angles & Sites

Parenteral administration involves drug injection into body tissues bypassing the gastrointestinal tract, ensuring rapid therapeutic bioavailability.

Intradermal (ID) Injections

Intradermal injections deposit minuscule fluid quantities into the vascular dermal layer just beneath the epidermis. Absorption is extremely slow, making it ideal for diagnostic skin testing and immunization:

• Clinical Indications: Mantoux tuberculin skin test (Purified Protein Derivative [PPD] 0.1 mL containing 5 tuberculin units), diagnostic allergy testing, and Bacillus Calmette–Guérin (BCG) vaccination.
• Technique: Use a 1 mL tuberculin syringe calibrated in hundredths of a milliliter. Hold the syringe almost flat against the skin at a 10° to 15° angle with the bevel facing upward. Advance the bevel through the epidermis until the tip is visible beneath the surface. Slowly inject solution; resistance should be felt. A discrete, pale, raised wheal (dermal bleb) measuring 6 to 10 mm in diameter will form immediately.
• Critical Nursing Rule: DO NOT MASSAGE or rub the site, and do not apply an adhesive bandage with direct pressure. Massaging disperses the antigenic agent into the subcutaneous capillaries, yielding a false-negative result.

Subcutaneous (SC) Injections

Subcutaneous injections deposit medication into loose connective adipose tissue beneath the dermis. Possessing fewer blood vessels than muscular beds, subcutaneous absorption is slow, steady, and sustained:

• Anatomical Sites:
  • Abdomen: Bounded by the costal margin superiorly, iliac crests inferiorly, and anterior superior iliac spines laterally. Stay at least 2 inches (5 cm) away from the umbilicus. The abdomen exhibits the fastest and most uniform absorption rate.
  • Upper Outer Arms: Posterior aspect of the arm over the triceps.
  • Anterior Thighs: Middle third of the anterior thighs.
  • Upper Buttocks / Flanks: Above the gluteal fold.
• Injection Angle: Insert at 45° when grasping a 1-inch fold of skin (or in cachectic individuals) or at 90° when grasping 2 inches of adipose tissue.
• Site Rotation and Lipodystrophy: Injection sites must be rotated systematically within an anatomical zone (e.g., maintaining 1 inch of distance between consecutive abdominal punctures) to prevent lipodystrophy (lipohypertrophy: fatty fibrocartilaginous lumps that impede drug absorption; or lipoatrophy: localized loss of fat tissue).
• Anticoagulant Protocol (Heparin & LMWH / Enoxaparin):
  • Inject exclusively into the anterolateral or posterolateral abdominal wall (the "love handles").
  • DO NOT ASPIRATE: Aspiration creates mechanical shear stress on microvessels, producing painful tissue trauma and extensive hematoma formation.
  • DO NOT MASSAGE: Rubbing the site post-injection drives tissue bleeding and ecchymosis.
  • Prefilled Syringe Air Bubble: For low-molecular-weight heparins (enoxaparin), do not expel the prefilled air bubble before injection; the air bubble acts as an air lock behind the drug, clearing the needle lumen and locking the medication within the subcutaneous plane.

Intramuscular (IM) Injections & Anatomical Landmarks

Intramuscular injections deposit medication into deep, vascular skeletal muscle tissue, providing faster therapeutic onset than subcutaneous routes and accommodating larger injection volumes:

1. Ventrogluteal Site (Gluteus Medius & Minimus):
   • Status: The evidence-based site of choice for all clients older than 7 months (infants, children, and adults).
   • Landmarks: Place the palm of the hand over the patient's greater trochanter (use the right hand for the left hip, or left hand for the right hip). Point the index finger toward the anterior superior iliac spine (ASIS), and spread the middle finger along the iliac crest toward the buttock. The injection site is directly in the center of the V-shaped triangle formed by the index and middle fingers.
   • Advantages: Deep muscle bed, thick muscle mass, thin subcutaneous fat, and completely free of major nerves and large blood vessels (safely distant from the sciatic nerve and superior gluteal artery).
2. Vastus Lateralis Site:
   • Status: Preferred site for neonates, infants, and toddlers (< 12 months) who lack developed gluteal musculature from walking.
   • Landmarks: Located on the anterolateral aspect of the middle third of the thigh. Divide the area between the greater trochanter of the femur superiorly and the lateral femoral condyle (knee) inferiorly into vertical thirds; the injection is delivered into the anterior lateral middle third.
3. Deltoid Muscle:
   • Status: Suitable only for small-volume injections (≤ 1.0 mL), primarily adult vaccinations (e.g., influenza, hepatitis B, tetanus toxoid, COVID-19).
   • Landmarks: Palpate the lower edge of the acromion process. The injection site is located 2 to 3 fingerbreadths (1 to 2 inches / 2.5 to 5 cm) below the acromion process, centered in the inverted triangular muscle bulk above the axilla.
   • Cautions: Proximity to the radial nerve, brachial artery, and axillary nerve requires precise landmarking; injecting too low risks permanent radial nerve palsy.
4. Dorsogluteal Site (Upper Outer Quadrant of Buttock):
   • Status: Avoided whenever another site is suitable. Some protocols still name it—for example, the deep gluteal injections of the Pritchard magnesium sulfate regimen—so the upper outer quadrant must then be landmarked precisely.
   • Clinical Rationale: Historically identified by dividing the buttock into quadrants, the dorsogluteal site carries a high risk of catastrophic sciatic nerve puncture (causing permanent foot drop, chronic pain, and paresis) and accidental cannulation of the superior gluteal artery. Furthermore, thick subcutaneous adipose tissue frequently results in inadvertent subcutaneous deposition, leading to sterile abscesses and erratic absorption.

---

4. The Z-Track Technique for Intramuscular Injections

The Z-track method is an evidence-based intramuscular injection technique designed to prevent medication from tracking backward along the needle path into the subcutaneous tissue and skin.

Clinical Indications

• Irritating, caustic, or hypertonic medications (e.g., hydroxyzine, haloperidol, chlorpromazine).
• Medications that stain the skin and subcutaneous tissue dark or brown (e.g., iron dextran).
• Older adults or cachectic patients with loose subcutaneous tissue.

Step-by-Step Z-Track Procedure